Petra E. M. Balbi

Petra E. M. Balbi

Auto-generated profile, based on publicly available information

Petra E. M. Balbi

Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
CGCasper A. Goverde
Casper A. Goverde
MPMartin Pacesa
Martin Pacesa
NGNicolas Goldbach
Nicolas Goldbach
LDLars J. Dornfeld
Lars J. Dornfeld
PBPetra E. M. Balbi
Petra E. M. Balbi
BCBruno E. Correia
Bruno E. Correia
De novo design of complex protein folds using solely computational means remains a significant challenge. Here, we use a robust deep learning pipeline to design complex folds and soluble analogues of integral membrane proteins. Unique membrane topologies, such as those from GPCRs, are not found in the soluble proteome and we demonstrate that their structural features can be recapitulated in solution. Biophysical analyses reveal high thermal stability of the designs and experimental structures show remarkable design accuracy. The soluble analogues were functionalized with native structural motifs, standing as a proof-of-concept for bringing membrane protein functions to the soluble proteome, potentially enabling new approaches in drug discovery. In summary, we designed complex protein topologies and enriched them with functionalities from membrane proteins, with high experimental success rates, leading to a de facto expansion of the functional soluble fold space.

28 January 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PBPetra E. M. Balbi
Petra E. M. Balbi
ASAhmed Sadek
Ahmed Sadek
Anthony MarchandAnthony Marchand
Anthony Marchand
TYTa-Yi Yu
Ta-Yi Yu
JDJovan Damjanovic
Jovan Damjanovic
BCBruno E. Correia
Bruno E. Correia
The human cell surfaceome, integral to cell communication and disease mechanisms, presents a prime target for therapeutic intervention. De novo protein binder design against these cell surface proteins offers a promising yet underexplored strategy for drug development. However, the vast search space and limited data on natural or competitive binders have historically limited experimental success. In this study, we systematically analyzed the entire human surfaceome, identifying approximately 4,500 targetable sites and introducing potential binding seeds for initiating protein design applications. To validate these seeds, we implemented two experimental approaches (protein scaffolding and peptide cyclization) on three representative targets (FGFR2, IFNAR2, and HER3). Our results revealed a high success rate, showing that seeds provide valuable starting points for binder design against our identified targetable sites, as well as the need for constant improvements of computational protein design pipelines utilizing machine learning and physics-based methods. Additionally, we present SURFACE-Bind, an interactive database offering open access to all generated data. The high-throughput computational design methods and target-specific binder seeds established here pave the way for a new generation of targeted therapeutics for the human surfaceome.